← SynDRA
VENGLUSTAT
SynDRA canonical compound SYN0039707 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | UGCG |
|---|
| Mechanism of action | glucosylceramidase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- UGCG INHIBITOR
- Ceramide glucosyltransferase inhibitor
- glucosylceramidase inhibitor
Drug classes
Cross-references
Synonyms
- GENZ-682452
- GZ402671
- Ibiglustat
- GZ-402671
- GZ/SAR-402671
- GZ/SAR402671
- Genz-682452-AA
- SAR-402671
- SAR402671
- UNII-BLP1XA3FZA
- BLP1XA3FZA
- (S)-Quinuclidin-3-yl (2-(2-(4-fluorophenyl)thiazol-4-yl)propan-2-yl)carbamate
- Ibiglustat [INN]
- SCHEMBL12615329
- YFHRCLAKZBDRHN-MRXNPFEDSA-N
- Ibiglustat(Genz-682452 pound(c)
- GZ-452
- ZINC202143443
- AKOS027337125
- CS-6512
- Carbamic acid, N-(1-(2-(4-fluorophenyl)-4-thiazolyl)-1-methylethyl)-, (3S)-1-azabicyclo(2.2.2)oct-3-yl ester
- (3S)-1-Azabicyclo(2.2.2)octan-3-yl N-(2-(2-(4-fluorophenyl)-1,3-thiazol-4-yl)propan-2-yl)carbamate
- GZ4026
- Genz-682452
- string
- venglustatum
- RefChem:901786
- MFCD28502073
- Venglustat [USAN]
- Ibiglustat(Genz-682452
- C20H24FN3O2S
- VENGLUSTAT [INN]
- Venglustat (USAN/INN)
- VENGLUSTAT [WHO-DD]
- orb1302829
- GTPL11550
- GLXC-10681
- EX-A1870
- BDBM50593123
Look up VENGLUSTAT in the interactive SynDRA portal →